Detalles de la búsqueda
1.
Ustekinumab Is Associated with Real-World Long-Term Effectiveness and Improved Health-Related Quality of Life in Crohn's Disease.
Dig Dis Sci
; 68(1): 65-76, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35459973
2.
Prospective observational study on Stelara (ustekinumab) assessing effectiveness in Crohn's disease (PROSE): a 16-week follow-up.
Scand J Gastroenterol
; 56(6): 680-686, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794731
3.
Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG).
Scand J Gastroenterol
; 52(6-7): 722-729, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28362144
4.
Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study.
Therap Adv Gastroenterol
; 17: 17562848241242700, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38655034
5.
Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study.
Therap Adv Gastroenterol
; 16: 17562848231174953, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37274297
6.
Ustekinumab treatment in ulcerative colitis: Real-world data from the Swedish inflammatory bowel disease quality register.
United European Gastroenterol J
; 10(7): 631-639, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35834389
7.
Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study.
Therap Adv Gastroenterol
; 14: 17562848211023386, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34276808
8.
Retrospective Single Center Study of Granulocyte Monocyte Adsorption Apheresis Treatment in Inflammatory Bowel Disease.
Ther Apher Dial
; 20(1): 79-85, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26841133
Resultados
1 -
8
de 8
1
Próxima >
>>